-
EP1677756
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1677756
| EP1677756 - ADMINISTRATION OF LEVODOPA AND CARBIDOPA [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 03.10.2008 Database last updated on 30.10.2024 | Most recent event Tooltip | 03.10.2008 | Application deemed to be withdrawn | published on 05.11.2008 [2008/45] | Applicant(s) | For all designated states ALZA Corporation 1900 Charleston Road, P.O. Box 7210 Mountain View, CA 94039-7210 / US | [N/P] |
| Former [2006/28] | For all designated states ALZA CORPORATION 1900 Charleston Road, P.O. Box 7210 Mountain View, CA 94039-7210 / US | Inventor(s) | 01 /
WONG, Patrick, S., L. 1533 Burlingame Avenue Burlingame, CA 94010 / US | 02 /
YAN, Dong 10134 Congress Place Cupertino, CA 95014 / US | 03 /
HWANG, Stephen 818 Fielding Drive Palo Alto, CA 94303 / US | 04 /
GUITTARD, George, V. 10134 Congress Place Cupertino, CA 95014 / US | [2006/28] | Representative(s) | Williams, Paul Edwin, et al Ablett & Stebbing 7-8 Market Place London W1W 8AG / GB | [N/P] |
| Former [2006/28] | Williams, Paul Edwin, et al Ablett & Stebbing Caparo House 101-103 Baker Street London W1U 6FQ / GB | Application number, filing date | 04810117.4 | 29.10.2004 | [2006/28] | WO2004US36039 | Priority number, date | US20030516259P | 31.10.2003 Original published format: US 516259 P | US20030519509P | 12.11.2003 Original published format: US 519509 P | [2006/28] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2005041924 | Date: | 12.05.2005 | Language: | EN | [2005/19] | Type: | A2 Application without search report | No.: | EP1677756 | Date: | 12.07.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.05.2005 takes the place of the publication of the European patent application. | [2006/28] | Search report(s) | International search report - published on: | EP | 10.11.2005 | Classification | IPC: | A61K9/00, A61K9/20, A61K31/198, A61K31/20, A61P3/10, C07C229/34 | [2006/28] | CPC: |
A61K31/662 (EP,US);
A61K47/50 (KR);
A61K31/155 (EP,US);
A61K31/185 (EP,US);
A61K31/195 (EP,US);
A61K31/197 (EP,US);
A61K31/198 (EP,US);
A61K31/20 (EP,US);
A61K31/295 (EP,US);
A61K31/66 (EP,US);
A61K33/26 (EP,US);
A61K47/44 (KR);
A61K47/541 (EP,US);
A61K47/585 (EP,US);
A61K9/0004 (EP,US);
A61P25/00 (EP);
A61P25/04 (EP);
A61P25/08 (EP);
A61P25/16 (EP);
A61P3/10 (EP);
A61P43/00 (EP);
A61P7/06 (EP)
(-)
| C-Set: |
A61K31/155, A61K2300/00 (US,EP);
A61K31/185, A61K2300/00 (US,EP);
A61K31/197, A61K2300/00 (US,EP);
A61K31/198, A61K2300/00 (US,EP);
A61K31/20, A61K2300/00 (EP,US);
A61K31/66, A61K2300/00 (EP,US); | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/28] | Extension states | AL | Not yet paid | HR | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | Title | German: | VERABREICHUNG VON LEVODOPA UND CARBIDOPA | [2006/28] | English: | ADMINISTRATION OF LEVODOPA AND CARBIDOPA | [2006/28] | French: | ADMINISTRATION DE LEVODOPA ET DE CARBIDOPA | [2006/28] | Entry into regional phase | 17.05.2006 | National basic fee paid | 17.05.2006 | Designation fee(s) paid | 17.05.2006 | Examination fee paid | Examination procedure | 27.05.2005 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 17.05.2006 | Examination requested [2006/28] | 07.07.2006 | Amendment by applicant (claims and/or description) | 02.01.2008 | Despatch of a communication from the examining division (Time limit: M04) | 14.05.2008 | Application deemed to be withdrawn, date of legal effect [2008/45] | 18.06.2008 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2008/45] | Fees paid | Renewal fee | 12.10.2006 | Renewal fee patent year 03 | 12.10.2007 | Renewal fee patent year 04 | 31.03.2008 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]US3916004 (OKADA RYUZO, et al) [X] 1-32 * column 2, line 23 - column 3, line 4 *; | [X]US4729989 (ALEXANDER JOSE [US], et al) [X] 1-32,88-91 * column 1, line 35 - column 2, line 3 * * column 4, line 13 * * column 5, line 35 *; | [X]EP0260236 (LEJUS MEDICAL AB [SE]) [X] 65-77,92-98 * column 1, line 5 - line 15 *; | [X]WO03005967 (TEVA PHARMA [IL], et al) [X] 1-32,88-91 * examples 1-5 *; | [X]WO03041646 (TEVA PHARMA [IL], et al) [X] 1-32,88-91 * the whole document * * page 6, line 24 *; | [X]WO03053400 (ALZA CORP [US]) [X] 1-32,88-91 * page 6, line 4 * * page 6, line 24 *; | [X] - CAMPBELL R R A ET AL, "THE EFFECT OF FERROUS SULFATE AND PH ON L DOPA ABSORPTION", CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, (1990), vol. 68, no. 5, ISSN 0008-4212, pages 603 - 607, XP009045786 [X] 1 * page 605, column 1, paragraph L * | [A] - SASAHARA K ET AL, "DOSAGE FORM DESIGN FOR IMPROVEMENT OF BIO AVAILABILITY OF L DOPA 5. ABSORPTION AND METABOLISM OF L DOPA IN INTESTINAL SEGMENTS OF DOGS", JOURNAL OF PHARMACEUTICAL SCIENCES, (1981), vol. 70, no. 10, ISSN 0022-3549, pages 1157 - 1160, XP009045807 [A] 1-32,88-91 * the whole document * DOI: http://dx.doi.org/10.1002/jps.2600701018 |